Well, the language of the announcement was kind of funky. I"m surprised the stock price got as much of a rise as it did. What does "conditional approval" mean, anyway? Someone coming new to the stock, other than a day trader, would have to think twice before taking that announcement seriously.
Well, guys, I have to admit, you have won me over to your side. I cannot comment on the management presentation style, because I have not seen it, and I will not comment on their wardrobe style, because that is a cheap ad hominem fallacy, but perhaps it is time to have an energetic, articulate member of the management who can play both offense and defense with our company's progress.
Definately? Root, who taught you to spell?
It's definitely, as in finite, or what is definitely not finite, infinity.
The answer to your question is "No," because they rang the CLOSING bell. Now, if they had rung the opening bell, the answer might have been "Yes."
Thanks, cgq. Let's hope for all of us that 66 is indeed not "old dude territory" anymore.
We need more time, after all, to enjoy the rewards for all our patience with CGEN when they finally come through.
Thanks to all for the informative posts, as usual. The CGEN board is the only one I am aware of where the debate carries forward with the most civility and clarity of any others.
And thanks for the good wishes. My recovery is slow but steady, and from all I have read by other patients with a similar treatment protocol, my progress is on track.and just about where it should be now. Four to six weeks is the usual necessary time for an old guy like me, 66, to get beyond the major discomfort, and six months to a year for full recovery not being unusual.
I see the surgeon/urologist on Friday and will know better then when he advises the next phase, the radiation treatments, should begin. I will also ask him about any recent news on immune therapies, to let him know I would be a willing participant in any trials in my neck of the woods.
You have a good question concerning the comparison of insider ownership with ROSG. If you have the answer, please share it. I suspect that there are many other biotech companies without the insider ownership that small, independent investors like to see.
The fact that Berlin bought any shares is a positive to me -- and while I don't doubt any of the conspiracy theories that people are suggesting behind the buy, they are just that, theories.
You really don't get biotechnology stock action, do you? You could see shares unloaded every five cents up to ten dollars, and one strong news release, and they are immediately covered, sold, or removed. And, really, your overuse of modifiers "Berlin's pitifully small buy... to prine his forth-coming pump" -- yeah, yeah. Your obvious bias makes for "pitifully bad writing."
I understand you just want to bash for your portfolio's sake, but do it with a bit of class.
cgq, I agree that the interest of BP in small biotech firms does indeed make a significant difference in catching the attention of Wall Street. But only when the FDA enters the picture and provides true bona fide acceptance of the company's product, will we see the kind of rush to own shares that we are all waiting for.. BP interest catches the attention of Wall Street traders because many traders are in for the short-term and hope their timing is right for a buy-out, They will bail, even short-sell, and depress the stock price once again if no deal is forthcoming or the deal is less than expected. My point is that BP attention is a double-edged sword. Yes, there are definite benefits, but I'm not sure the consequences are always positive. We need proof of product viability here, and that usually means a government seal of approval.
Thanks, rpthom. . I found many forums where men who had gone through the TURP process explained their day by day recovery, and that has been very helpful to keep my own anxiety down. It helps a guy to know what is the usual pain and leakage, so that he doesn't get excited about such occurrences as they happen. Here are two words I wish my doctor or the nurses would have explained in greater detail to me just before or after the procedure:: bladder spasm. I freaked out when it happened because 1. it is terribly painful, and 2. since I didn't know about it, I had no idea what was happening. Fortunately, I was still in the hospital. So, if you ever need a catheter, learn about bladder spasms. I now know they continue after the TURP for several weeks even after the catheter is removed, so that won't' come as a surprise.
I was advised to buy absorbent pads for when the catheter is removed, and bought the strongest I could get, which are called (I kid you not) "surge protectors." The flood pun was obvious, but I don't know if the marketing department got the electrical pun: a pretty good way to describe the pain of a bladder spasm is that it is like being hooked up to one of those battery torture devices we see in spy movies.
It sounds like you are saying his buying was a sell signal. I never heard that one before. Usually insider buying is a just that, a buy signal. What would Berlin have to gain by buying just before hedges short the stock or the company dilutes its shares? Why would he do that? It just doesn't make sense.
Yes, excellent additional points to my comments. We do indeed need further fundamental reasons for any financial commentator to make a positive recommendation. As usual, we are caught in the same old time-trap -- we can see the finish line, but the long distance to get there (the real, validated, scientific evidence with commercial importance) makes it seem as though we are moving at a snail's pace.
And thanks for the kind comments about the surgery. I have prostate cancer, and have opted to go through a two stage process: first the TURP, then radiation. I am not a candidate for robotic surgery, or I would have opted for that. The Trans Urethral Resection of the Prostate is a routine surgery, and is often done for BPH when medications like Flomax and Proscar are no longer effective. In my case, the enlarged prostate might have caused problems from the radiation, so the reduction in size first was recommended. My surgeon requires a week with a catheter after the TURP, so that's been a real "drag" on my day.
Most of Cramer's comments come from his conversations with his trading buddies at investment houses and hedge funds. If they are willing to tell him they are buying a stock, he says he likes it; if they are willing to tell him they are selling a stock, or at least not buying it, he says he does not like it. In other words, he is the messenger, not the source of information. He is not a Peter Lynch or Warren Buffet who understands the company in total, he just reports what others have decided. Griping about Cramer is merely griping about the financial managers on Wall Street in general who give him their opinions.
Since I hold a major portion of my portfolio in CGEN, a message from Cramer not to buy CGEN is dispiriting, and leaves me with growing doubts in my investment here. Not because "Cramer says it," but because of the poeple whom he listens to say it. We are once again reminded that this company has no support on Wall Street, and the belief that its science is superior to the science of other similar companies has yet to be accepted.
I hate to throw another wet blanket on our already dampened expectations, but his comment is just one more piece of evidence that this stock is not going higher for a long time to come. If no one on Wall Street is willing to back CGEN up and let know Cramer that they do, then we are looking down into a very deep chasm.
I would truly like to be rebutted here point by point. So, don't hold back on any opposite views that can counter the position I have just put forward.
no, you mean jetsyahearme is a two DUMP chump. He be bashin, not pumpin. And the stink comes right through the screen.
Some small medical products companies have the ability to prove their viability with an array of services that take time to become part of the mainstream diagnostic/treatment regimen. ROSG will be one of those companies, and Berlin is guiding the company in that direction of organic growth and independence. His potential legacy is not purely to make the most of a golden parachute, but to make the most of a company that will become a standard bearer for cancer mRNA diagnostics.
If the company is going up for sale, it will be in 2020, at a share price at least ten times the current one.
There are new investors here who are hoping to make a quick buck on a trade they only entered a year or two ago, and other investors who have been here for five or more years and are deeply (and understandably) embittered by the losses we have incurred. Now is not the time to give in to the greed or the frustration, but to hold with the knowledge that this company can thrive with its growing recognition.
I am a long-term holder, with a loss that amounts to tens of thousands of dollars, so I am obviously speaking from the standpoint of a patient investor who wants to see that patience rewarded exponentially, not in a few dollar buyout.
I know some people prefer not to see the weakness in certain stocks as hedge fund driven manipulation, but I cannot see any other reason for the bear attack on several micro cap biotechnology stocks in the past few week. If anyone has a better answer than that HFT and colluding hedge funds are behind this sell off, please let me know.
IBB, with names that are well-known and defended by large mutual funds, was strong today. That tells me that predatory traders are seeking out names that have no strong backing. And that tells me that this weakness in a sub-sub-sub-sector has probably offered a good buying opportunity.